Company has no debt since last 5 years. (Source: Consolidated Financials)
Fortis Malar Hospitals Share Price
Fortis Malar Hospitals ...
Fortis Malar share price insights
Company witnessed QoQ revenue decline of 88.57%, which is lowest in the last 3 years. (Source: Consolidated Financials)
Stock gave a 3 year return of -15.23% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Company has spent 7.29% of its operating revenues towards interest expenses and 25.7% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Fortis Malar Hospitals Ltd. share price moved down by -0.03% from its previous close of Rs 61.99. Fortis Malar Hospitals Ltd. stock last traded price is 61.97
Share Price Value Today/Current/Last 61.97 Previous Day 61.99
Key Metrics
PE Ratio (x) | 2.41 | ||||||||||
EPS - TTM (₹) | 25.71 | ||||||||||
MCap (₹ Cr.) | 116.14 | ||||||||||
Sectoral MCap Rank | 31 | ||||||||||
PB Ratio (x) | 1.06 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| 0.55 | ||||||||||
VWAP (₹) | 61.40 | ||||||||||
52W H/L (₹) |
Fortis Malar Share Price Returns
1 Day | -0.03% |
1 Week | 2.13% |
1 Month | -4.2% |
3 Months | -2.15% |
1 Year | 9.33% |
3 Years | -15.23% |
5 Years | 25.96% |
Fortis Malar News & Analysis
Fortis Malar Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Fortis Malar Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Quarterly Topline Performance
Company witnessed QoQ revenue decline of 88.57%, which is lowest in the last 3 years. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent 7.29% of its operating revenues towards interest expenses and 25.7% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 0.83 7.28 18.84 20.46 19.37 Total Income Growth (%) -88.57 -61.35 -7.91 5.63 -14.40 Total Expenses 0.89 -51.83 21.58 20.95 20.95 Total Expenses Growth (%) -101.72 -340.18 3.00 0.02 -10.39 EBIT -0.06 59.11 -2.74 -0.49 -1.57 EBIT Growth (%) -100.10 - - - - Profit after Tax (PAT) -0.06 54.05 -4.00 -1.79 -2.93 PAT Growth (%) -100.12 - - - - EBIT Margin (%) -6.98 811.74 -14.52 -2.39 -8.13 Net Profit Margin (%) -7.75 742.21 -21.24 -8.76 -15.12 Basic EPS (₹) -0.03 28.84 -2.14 -0.96 -1.56 All figures in Rs Cr, unless mentioned otherwise
Insights
Zero Debt Burden
Company has no debt since last 5 years. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 115.88 138.00 160.91 169.10 193.55 Total Assets Growth (%) -16.03 -14.24 -4.84 -12.63 28.30 Total Liabilities - 73.83 80.78 80.35 97.14 Total Liabilities Growth (%) -100.00 -8.61 0.53 -17.28 113.61 Total Equity 109.47 64.17 80.13 88.74 96.41 Total Equity Growth (%) 70.59 -19.92 -9.71 -7.95 -8.51 Current Ratio (x) 17.68 2.66 1.56 2.43 1.74 Total Debt to Equity (x) 0.00 0.00 0.00 0.00 0.00 Contingent Liabilities - - - - - All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities -7.30 5.61 6.84 -0.86 -0.30 Net Cash used in Investing Activities 119.70 0.50 8.23 -27.51 49.88 Net Cash flow from Financing Activities -10.85 -12.65 -10.10 -7.25 -11.57 Net Cash Flow 101.55 -6.54 4.98 -35.62 38.01 Closing Cash & Cash Equivalent 107.41 5.86 12.40 7.43 43.05 Closing Cash & Cash Equivalent Growth (%) 1,732.70 -52.75 66.98 -82.75 754.71 Total Debt/ CFO (x) 0.00 0.00 0.00 0.00 0.00 All figures in Rs Cr, unless mentioned otherwise
Insights
ROE Outperforming 5 Year Average
Company delivered ROE of 41.4% in year ending Mar 31, 2024 outperforming its 5 year avg. of 1.1%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 41.40 -24.12 -10.32 -8.86 -9.22 Return on Capital Employed (%) -3.29 -0.88 -1.31 -7.59 -2.61 Return on Assets (%) 39.11 -11.21 -5.14 -4.65 -4.59 Interest Coverage Ratio (x) 1.34 1.85 1.65 -1.52 -0.53 Asset Turnover Ratio (x) 0.46 0.58 0.53 40.94 57.80 Price to Earnings (x) 1.93 -5.78 -13.09 -13.23 -9.07 Price to Book (x) 0.80 1.39 1.35 1.17 0.84 EV/EBITDA (x) -3.62 7.14 8.83 47.25 4.45 EBITDA Margin (%) 9.74 13.04 12.56 2.76 7.51
Fortis Malar Peer Comparison
Fortis Malar Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -15.23% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Stock Returns vs BSE Healthcare
Stock generated -15.23% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -15.23% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Stock Returns vs BSE Healthcare
Stock generated -15.23% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Fortis Malar Board Meeting/AGM
Fortis Malar Dividends
- Others
Meeting Date Announced on Purpose Details Jul 22, 2024 Jul 15, 2024 Board Meeting Quarterly Results May 17, 2024 May 10, 2024 Board Meeting Audited Results Apr 12, 2024 Apr 08, 2024 Board Meeting Interim Dividend Apr 08, 2024 Mar 28, 2024 Board Meeting Interim Dividend Feb 05, 2024 Jan 29, 2024 Board Meeting Quarterly Results Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 25% 2.5 Jul 24, 2024 May 17, 2024 Interim 400% 40.0 Apr 23, 2024 Apr 01, 2024 Final 5% 0.5 Sep 14, 2015 Apr 29, 2015 Interim 5% 0.5 Sep 19, 2013 Aug 30, 2013 Final 5% 0.5 - May 24, 2016 All Types Ex-Date Record Date Announced on Details Rights Apr 07, 1995 May 03, 1995 Mar 16, 1995 Rights ratio: 1 share for every 3 held at a price of Rs 10.0
About Fortis Malar
Fortis Malar Hospitals Ltd., incorporated in the year 1989, is a Small Cap company (having a market cap of Rs 116.14 Crore) operating in Hospitals & Allied Services sector. Fortis Malar Hospitals Ltd. key Products/Revenue Segments include Hospital Services and Other Operating Revenue for the year ending 31-Mar-2024. Show More
Executives
Auditors
- DS
Daljit Singh
Chairman, Non Ind & Non Exe DirectorCRChandrasekar Ramasamy
Whole Time DirectorRSRicha Singh Debgupta
Non Exe.Non Ind.DirectorRLRamesh L Adige
Ind. Non-Executive DirectorShow More - B S R & Co. LLP
Industry
Key Indices Listed on
-
Address
Fortis Hospital,Sector 62,Mohali, Punjab - 160062
More Details
FAQs about Fortis Malar share
- 1. What's Fortis Malar share price today and what are Fortis Malar share returns ?Fortis Malar share price was Rs 61.97 as on 29 Aug, 2024, 03:42 PM IST. Fortis Malar share price was down by 0.03% based on previous share price of Rs. 62.06.
- 2. What's the market capitalization of Fortis Malar?Within the Hospitals & Allied Services sector, Fortis Malar stock has a market cap rank of 31. Fortis Malar has a market cap of Rs 116.14 Cr.
- 3. What are the key metrics to analyse Fortis Malar Share Price?Key Metrics for Fortis Malar are:
- PE Ratio of Fortis Malar is 2.41
- Price/Sales ratio of Fortis Malar is 1.48
- Price to Book ratio of Fortis Malar is 1.06
- 4. Is Fortis Malar giving dividend?An equity Final dividend of Rs 2.5 per share was declared by Fortis Malar Hospitals Ltd. on 17 May 2024. So, company has declared a dividend of 25% on face value of Rs 10 per share. The ex dividend date was 24 Jul 2024.
- 5. What is the PE & PB ratio of Fortis Malar?The PE ratio of Fortis Malar stands at 2.41, while the PB ratio is 1.06.
- 6. What is the CAGR of Fortis Malar?The CAGR of Fortis Malar is -3.92.
- 7. What are the Fortis Malar quarterly results?Total Revenue and Earning for Fortis Malar for the year ending 2024-03-31 was Rs 65.96 Cr and Rs 45.32 Cr on Consolidated basis. Last Quarter 2024-06-30, Fortis Malar reported an income of Rs 0.83 Cr and loss of Rs -0.06 Cr.
- 8. What is 52 week high/low of Fortis Malar share price?Fortis Malar share price saw a 52 week high of Rs 107.94 and 52 week low of Rs 44.00.
- 9. Who are peers to compare Fortis Malar share price?Top 10 Peers for Fortis Malar are Lotus Eye Hospital and Institute Ltd., ANG Lifesciences India Ltd., Tejnaksh Healthcare Ltd., Medinova Diagnostic Services Ltd., Chennai Meenakshi Multispeciality Hospital Ltd., Soni Medicare Ltd., Dhanvantri Jeevan Rekha Ltd., Looks Health Services Ltd., Dolphin Medical Services Ltd. and KMC Speciality Hospitals (India) Ltd.
- 10. Who's the chairman of Fortis Malar?Daljit Singh is the Chairman, Non Ind & Non Exe Director of Fortis Malar
- 11. What are the returns for Fortis Malar share?Return Performance of Fortis Malar Shares:
- 1 Week: Fortis Malar share price moved up by 2.13%
- 3 Month: Fortis Malar share price moved down by 2.15%
- 6 Month: Fortis Malar share price moved up by 17.61%
- 12. Who are the key owners of Fortis Malar stock?Promoter,DII owns 62.71, 0.07 and shares of Fortis Malar as on 30 Jun 2024
- There is no change in promoter holding from 31 Mar 2024 to 30 Jun 2024
- There is no change in Domestic Institutional Investors holding from 31 Mar 2024 to 30 Jun 2024
- There is no change in Other investor holding from 31 Mar 2024 to 30 Jun 2024
Trending in Markets
Fortis Malar Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.